
    
      Influenza Virus Vaccine (Split Virion, Inactivated) that do not contains Preservative. HA
      contents 15μg/0.5ml per dose includ H1N1、H3N2 and B.

      Inactivated Split Influenza Vaccine was manufactured by Sanofi Pasteur HA contents 15μg/0.5ml
      per dose includ H1N1、H3N2 and B.

      This is a randomized, blind phase 3 clinical trial. Total 1200 adults (above ages 36 months )
      were selected, randomized to two groups [Influenza Virus Vaccine (Split Virion, Inactivated)
      and Inactivated Split Influenza Vaccine , each group n=600], adults in each group will be
      vaccinated with one dose of either Influenza Virus Vaccine (Split Virion, Inactivated) or
      Sanof IVV respectively.
    
  